Maternal deaths in women with lupus nephritis: A review of published evidence

J. Ritchie, A. Smyth, C. Tower, M. Helbert, M. Venning, Vesna D Garovic

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background and objectives: Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to perform a literature review of the maternal deaths in women with SLE and lupus nephritis to: (1) identify the main causes of death and (2) discuss possible reasons for these causes, and strategies that may improve patient care and outcomes. Design, setting, participants, and measurement: We performed an extensive electronic literature search from 1962 to 2009 using online databases (PubMed, Embase, Lilacs, Cochrane Controlled Trials Register, Medline, and Science Citation Index). Studies were included if they reported pregnancies in patients with SLE and lupus nephritis with at least one reported maternal death. Results: We identified 13 studies that reported a total of 17 deaths in the 6 week post-partum period that were attributable to SLE and lupus nephritis. In all cases, death occurred in the setting of active disease, and was attributed either to infection in 41.2% (n = 7), or disease activity in 29.4% (n = 5). The remaining deaths were due to pulmonary embolus in 11.8% (n = 2), pregnancy-associated cardiomyopathy in 5.9% (n = 1), adrenal failure due to abrupt steroid withdrawal in 5.9% (n = 1), and undefined in 5.9% (n = 1). Conclusions: All maternal deaths in patients with SLE and lupus nephritis occurred in those with active disease, with disease activity/complications and infections (mainly opportunistic) being the two major causes. The presented evidence further supports timing of pregnancy relative to SLE activity, and the judicious use of immunosuppressive agents in pregnant patients.

Original languageEnglish (US)
Pages (from-to)534-541
Number of pages8
JournalLupus
Volume21
Issue number5
DOIs
StatePublished - Apr 2012

Fingerprint

Maternal Death
Lupus Nephritis
Systemic Lupus Erythematosus
Pregnancy
Opportunistic Infections
Immunosuppressive Agents
Embolism
Cardiomyopathies
PubMed
Cause of Death
Patient Care
Steroids
Mothers
Databases
Lung
Infection

Keywords

  • disease activity
  • infection
  • lupus nephritis
  • maternal death
  • pregnancy
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Maternal deaths in women with lupus nephritis : A review of published evidence. / Ritchie, J.; Smyth, A.; Tower, C.; Helbert, M.; Venning, M.; Garovic, Vesna D.

In: Lupus, Vol. 21, No. 5, 04.2012, p. 534-541.

Research output: Contribution to journalArticle

Ritchie, J, Smyth, A, Tower, C, Helbert, M, Venning, M & Garovic, VD 2012, 'Maternal deaths in women with lupus nephritis: A review of published evidence', Lupus, vol. 21, no. 5, pp. 534-541. https://doi.org/10.1177/0961203311434939
Ritchie, J. ; Smyth, A. ; Tower, C. ; Helbert, M. ; Venning, M. ; Garovic, Vesna D. / Maternal deaths in women with lupus nephritis : A review of published evidence. In: Lupus. 2012 ; Vol. 21, No. 5. pp. 534-541.
@article{a4a68c6bbf784dd78076391223d265a7,
title = "Maternal deaths in women with lupus nephritis: A review of published evidence",
abstract = "Background and objectives: Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to perform a literature review of the maternal deaths in women with SLE and lupus nephritis to: (1) identify the main causes of death and (2) discuss possible reasons for these causes, and strategies that may improve patient care and outcomes. Design, setting, participants, and measurement: We performed an extensive electronic literature search from 1962 to 2009 using online databases (PubMed, Embase, Lilacs, Cochrane Controlled Trials Register, Medline, and Science Citation Index). Studies were included if they reported pregnancies in patients with SLE and lupus nephritis with at least one reported maternal death. Results: We identified 13 studies that reported a total of 17 deaths in the 6 week post-partum period that were attributable to SLE and lupus nephritis. In all cases, death occurred in the setting of active disease, and was attributed either to infection in 41.2{\%} (n = 7), or disease activity in 29.4{\%} (n = 5). The remaining deaths were due to pulmonary embolus in 11.8{\%} (n = 2), pregnancy-associated cardiomyopathy in 5.9{\%} (n = 1), adrenal failure due to abrupt steroid withdrawal in 5.9{\%} (n = 1), and undefined in 5.9{\%} (n = 1). Conclusions: All maternal deaths in patients with SLE and lupus nephritis occurred in those with active disease, with disease activity/complications and infections (mainly opportunistic) being the two major causes. The presented evidence further supports timing of pregnancy relative to SLE activity, and the judicious use of immunosuppressive agents in pregnant patients.",
keywords = "disease activity, infection, lupus nephritis, maternal death, pregnancy, Systemic lupus erythematosus",
author = "J. Ritchie and A. Smyth and C. Tower and M. Helbert and M. Venning and Garovic, {Vesna D}",
year = "2012",
month = "4",
doi = "10.1177/0961203311434939",
language = "English (US)",
volume = "21",
pages = "534--541",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Maternal deaths in women with lupus nephritis

T2 - A review of published evidence

AU - Ritchie, J.

AU - Smyth, A.

AU - Tower, C.

AU - Helbert, M.

AU - Venning, M.

AU - Garovic, Vesna D

PY - 2012/4

Y1 - 2012/4

N2 - Background and objectives: Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to perform a literature review of the maternal deaths in women with SLE and lupus nephritis to: (1) identify the main causes of death and (2) discuss possible reasons for these causes, and strategies that may improve patient care and outcomes. Design, setting, participants, and measurement: We performed an extensive electronic literature search from 1962 to 2009 using online databases (PubMed, Embase, Lilacs, Cochrane Controlled Trials Register, Medline, and Science Citation Index). Studies were included if they reported pregnancies in patients with SLE and lupus nephritis with at least one reported maternal death. Results: We identified 13 studies that reported a total of 17 deaths in the 6 week post-partum period that were attributable to SLE and lupus nephritis. In all cases, death occurred in the setting of active disease, and was attributed either to infection in 41.2% (n = 7), or disease activity in 29.4% (n = 5). The remaining deaths were due to pulmonary embolus in 11.8% (n = 2), pregnancy-associated cardiomyopathy in 5.9% (n = 1), adrenal failure due to abrupt steroid withdrawal in 5.9% (n = 1), and undefined in 5.9% (n = 1). Conclusions: All maternal deaths in patients with SLE and lupus nephritis occurred in those with active disease, with disease activity/complications and infections (mainly opportunistic) being the two major causes. The presented evidence further supports timing of pregnancy relative to SLE activity, and the judicious use of immunosuppressive agents in pregnant patients.

AB - Background and objectives: Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to perform a literature review of the maternal deaths in women with SLE and lupus nephritis to: (1) identify the main causes of death and (2) discuss possible reasons for these causes, and strategies that may improve patient care and outcomes. Design, setting, participants, and measurement: We performed an extensive electronic literature search from 1962 to 2009 using online databases (PubMed, Embase, Lilacs, Cochrane Controlled Trials Register, Medline, and Science Citation Index). Studies were included if they reported pregnancies in patients with SLE and lupus nephritis with at least one reported maternal death. Results: We identified 13 studies that reported a total of 17 deaths in the 6 week post-partum period that were attributable to SLE and lupus nephritis. In all cases, death occurred in the setting of active disease, and was attributed either to infection in 41.2% (n = 7), or disease activity in 29.4% (n = 5). The remaining deaths were due to pulmonary embolus in 11.8% (n = 2), pregnancy-associated cardiomyopathy in 5.9% (n = 1), adrenal failure due to abrupt steroid withdrawal in 5.9% (n = 1), and undefined in 5.9% (n = 1). Conclusions: All maternal deaths in patients with SLE and lupus nephritis occurred in those with active disease, with disease activity/complications and infections (mainly opportunistic) being the two major causes. The presented evidence further supports timing of pregnancy relative to SLE activity, and the judicious use of immunosuppressive agents in pregnant patients.

KW - disease activity

KW - infection

KW - lupus nephritis

KW - maternal death

KW - pregnancy

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=84859361243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859361243&partnerID=8YFLogxK

U2 - 10.1177/0961203311434939

DO - 10.1177/0961203311434939

M3 - Article

C2 - 22311940

AN - SCOPUS:84859361243

VL - 21

SP - 534

EP - 541

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 5

ER -